Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sonus refines strategic initiatives and focuses on development of SN-2310 in cancer

March 28, 2008

Oncolin changes name from Edgeline Holdings and provides update on activities

March 28, 2008

Novel erbB2 inhibitor shows efficacy in different preclinical cancer models

March 28, 2008

ARRY-520 shows less chemoresistance-inducing potential than paclitaxel in vitro

March 28, 2008

FDA approves IND application for use of Davanat to treat a breast cancer patient

March 27, 2008

FDA grants clearance to ProNAi to initiate phase I clinical trials of PNT-2258 for cancer

March 27, 2008

CHMP recommends approval of Zevalin as first-line consolidation therapy

March 27, 2008

RXR agonist NRX-4204 begins phase I trial

March 27, 2008

Treanda receives FDA approval for CLL

March 27, 2008

Array BioPharma files IND for ARRY-614 and initiates phase I clinical trial

March 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...